Targeting inflammation-induced Kasabach-Merritt phenomenon
- PMID: 35298606
- DOI: 10.1182/blood.2022015412
Targeting inflammation-induced Kasabach-Merritt phenomenon
Comment on
-
Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial.Blood. 2022 Mar 17;139(11):1619-1630. doi: 10.1182/blood.2021014027. Blood. 2022. PMID: 35030255 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources

